Fidelity MSCI Health Care Index ETF (FHLC)
| 49.85 Delayed Data As of 4:10pm ET |  +0.27 / +0.54%Today’s Change | 41.01 Today|||52-Week Range 51.64 | +0.22% Year-to-Date |
Investment Objective
The investment seeks to provide investment returns that correspond, before fees and expenses, generally to the performance of the MSCI USA IMI Health Care Index. The fund invests at least 80% of assets in securities included in the fund's underlying index. The fund's underlying index is the MSCI USA IMI Health Care Index, which represents the performance of the health care sector in the U.S. equity market. It may or may not hold all of the securities in the MSCI USA IMI Health Care Index. The fund is non-diversified.
Latest FHLC News
No recent news for Fidelity MSCI Health Care Index ETF.
Performance
| 1 month | -0.70% | 3 years | +15.83% | |
| 3 months | +11.95% | 5 years | +9.52% | |
| 1 year | +16.81% | Since inception | +13.27% |
Data through 01/28/2020
Quote Details
| Previous close | $49.58 |
| Open day’s range | 49.62 – 50.06 |
| Net asset value (NAV) | 49.57 (01/27/2020) |
| Daily volume | 151,948 |
| Average volume (3 months) | 150,285 |
Data as of 4:10pm ET, 01/28/2020
Peer Comparisonvs. Health ETFs
| FHLC | Category | |
|---|---|---|
| Performance 5-yr return | +9.52% | +8.75% |
| Expense Gross exp ratio | 0.08% | 1.25% |
| Risk 5 year sharpe ratio | 0.70 | 0.52 |
| Net assets | $1.7B | $3.2B |
| Average market cap | $65.5B | $43.9B |
| Average P/E | 25.6 | 27.7 |
| Dividend / Share | -- | 0.30% |
Competitors
| VHT Vanguard Health Care Index Fund ETF Shar... |
| XLV Health Care Select Sector SPDR® Fund |
| IXJ iShares Global Healthcare ETF |
Holdings
Top 5 SectorsPortfolio weighting
| Business service | -- |
| Consumer goods | -- |
| Consumer service | -- |
| Energy | -- |
| Financial service | -- |
Top 10 HoldingsPortfolio weighting
| JNJ Johnson & Johnson | 8.58% |
| UNH UnitedHealth | 6.21% |
| MRK Merck | 5.19% |
| PFE Pfizer | 4.83% |
| ABT Abbott Laboratories | 3.42% |
| MDT Medtronic PLC | 3.39% |
| BMY Bristol-Myers Squibb | 3.36% |
| AMGN Amgen | 3.22% |
| ABBV AbbVie | 2.92% |
| TMO Thermo Fisher Scientific Inc | 2.90% |
